AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Switglim M 0.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Switglim M 0.5mg/500mg Tablet

Diabex Duo 0.5mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with fast-acting glucose sources. Regular meals and carrying glucose tablets or juice are essential. Alcohol consumption should be limited due to its potential to lower blood sugar. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Individuals with a history of heart disease should inform their doctor before use. Pregnant or breastfeeding women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are necessary.

Uses of Switglim M 0.5mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Switglim M 0.5mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switglim M 0.5mg/500mg tablets should be administered with food.

Common Side effects of Switglim M 0.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Switglim M 0.5mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; do not chew, crush, or fracture it. Switglim M 0.5mg/500mg tablets should be administered with a meal.

How Switglim M 0.5mg/500mg Tablet works:

Switglim M tablets (0.5mg/500mg) contain glimepiride and metformin, two drugs that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Switglim M 0.5mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Switglim M 0.5mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Administration of Switglim M 0.5mg/500mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Switglim M 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. The medication is contraindicated in patients experiencing severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Switglim M 0.5mg/500mg Tablet to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver dysfunction, initiate therapy with a reduced Switglim M 0.5mg/500mg Tablet dosage; its use is contraindicated in cases of severe liver disease.

What if you forget to take Switglim M 0.5mg/500mg Tablet :

Should you forget to take a Switglim M 0.5mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Switglim M 0.5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Switglim M 0.5mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Switglim M 0.5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Switglim M 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for treating type 1 diabetes.
Switglim M 0.5mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Switglim M 0.5mg/500mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Switglim M 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Switglim M 0.5mg/500mg Tablet with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Switglim M 0.5mg/500mg Ta...
38
MRP 44
13% off